BRIEF published on 10/15/2024 at 07:35, 1 year 5 months ago MaaT Pharma Clinical Trial Recruitment Concluded Clinical Trial MaaT Pharma MaaT013 DSMB Notice AGvH Treatment
PRESS RELEASE published on 10/15/2024 at 07:30, 1 year 5 months ago Inside Information / Other news releases MaaT Pharma completes recruitment of its ARES Phase 3 Trial for MaaT013, a treatment for Acute Graft-versus-Host Disease, with topline results expected in January 2025 Clinical Trial MaaT Pharma MaaT013 ARES Phase 3 Trial Acute Graft-versus-Host Disease
BRIEF published on 09/04/2024 at 07:35, 1 year 7 months ago MaaT Pharma Announces Participation in Investor and Medical Conferences in September Investors Cancers Medical Conference MET Therapies Cell Transplantation
BRIEF published on 05/15/2024 at 07:35, 1 year 10 months ago MaaT Pharma successfully completes a fundraising of 19.2 million euros Biotechnology Fundraising Investment MaaT Pharma Clinical Tests
PRESS RELEASE published on 05/15/2024 at 07:30, 1 year 10 months ago Inside Information / News release on accounts, results MaaT Pharma announces successful completion of 19.2 million euros Global Offering with new shares, aims to fund R&D activities, Phase 3 trials, and broaden pipeline Biotechnology Fundraising Clinical Trials Global Offering MaaT Pharma
BRIEF published on 05/14/2024 at 19:39, 1 year 10 months ago MaaT Pharma Announces 18 Million Euro Global Offering and Strategic Developments Financial Strategy Phase 3 Trial Clinical-stage Biotechnology Global Offering Microbiome Ecosystem Therapies
PRESS RELEASE published on 05/14/2024 at 19:34, 1 year 10 months ago Inside Information / News release on accounts, results MaaT Pharma launches a global offering of approximately 18 million euros to fund R&D activities and expand shareholder base. Current shareholders commit to significant subscriptions Global Offering MaaT Pharma 18 Million Euros R&D Activities Shareholder Commitments
Published on 04/08/2026 at 08:05, 1 hour 28 minutes ago Tocvan Announces Addition of Second Drill Rig and Accelerates High-Priority Drill Targets at Flagship Gran Pilar Gold-Silver Project
Published on 04/08/2026 at 02:50, 6 hours 43 minutes ago Panther Minerals Announces Appointment of Rick Mah to Board of Directors
Published on 04/08/2026 at 01:35, 7 hours 58 minutes ago Polaris Renewable Energy Announces Q1 2026 Investor Call Details
Published on 04/08/2026 at 00:40, 8 hours 53 minutes ago Relevant Gold Announces Initial Closing of Strategic Financing
Published on 04/08/2026 at 00:10, 9 hours 23 minutes ago Trans Canada Gold Completes the Acquisition of the Harrison Lake District Scale Gold Property and First Tranche of the Non-Brokered Private Placement
Published on 04/08/2026 at 09:23, 9 minutes ago IBU-tec advanced materials AG: 2025 annual financial statements presented and dividend proposal of EUR 0.12 per share
Published on 04/08/2026 at 09:10, 22 minutes ago Reolink Announces Official Integration with Homey to Elevate Smart Home Automation
Published on 04/08/2026 at 09:05, 28 minutes ago Lenzing Commissions 14 MW Power‑to‑Heat Facility, Strengthening Grid Stability and Heat Management
Published on 04/08/2026 at 09:00, 32 minutes ago Original-Research: EPH Group AG (von NuWays AG): BUY
Published on 04/08/2026 at 09:00, 32 minutes ago Original-Research: ASMALLWORLD AG (von NuWays AG): BUY
Published on 04/08/2026 at 08:30, 1 hour 3 minutes ago Edenred Mobility and Electra form a strategic partnership to accelerate the electrification of commercial fleets in France
Published on 04/07/2026 at 17:57, 15 hours 35 minutes ago Peugeot Invest publishes its 2025 Universal Registration Document
Published on 04/07/2026 at 17:45, 15 hours 48 minutes ago ENGIE accelerates the deployment of battery storage with nearly 400 MW of new projects in Europe
Published on 04/07/2026 at 17:38, 15 hours 54 minutes ago Reporting on share buyback transactions carried out between March 30 and April 2, 2026
